Rhea Coler | Biomedical Sciences | Best Researcher Award

Posted on by The Scientist

Research Excellence Award

Rhea Coler
Affiliation Seattle Children’s Research Institute
Country United States
Scopus ID 7004227435
Documents 165
Citations 12,421
h-index 54
Subject Area Biomedical Sciences
Event The Scientist Global Awards

The Best Researcher Award recognizes research contributions, scholarly productivity, scientific influence, and sustained engagement with the advancement of knowledge. This academic recognition profile presents the supplied bibliometric information for Rhea Coler, affiliated with Seattle Children’s Research Institute in the United States, within the field of biomedical sciences. The profile is intended to provide an organized overview of research activity and its relevance to scientific recognition through The Scientist Global Awards.[1]

Abstract

This article documents a researcher profile prepared in the context of the Best Researcher Award presented through The Scientist Global Awards. The supplied information identifies Rhea Coler as a researcher affiliated with Seattle Children’s Research Institute in the United States, with a subject-area classification of biomedical sciences. The provided bibliometric indicators report 165 documents, 12,421 citations, and an h-index of 54. These measures offer a quantitative starting point for describing scholarly output and citation activity, but they do not independently establish research quality, individual contribution, or eligibility for an award.  [1]

Keywords

Best Researcher Award; Rhea Coler; biomedical sciences; research evaluation; bibliometrics; scientific publications; citation analysis; h-index; scholarly impact; Seattle Children’s Research Institute; The Scientist Global Awards.

Introduction

The Best Researcher Award profile for Rhea Coler brings together the researcher details and bibliometric figures supplied for this article. The profile identifies Seattle Children’s Research Institute as the stated institutional affiliation and biomedical sciences as the subject area. The linked Scopus record provides a starting point for independent verification of the author identifier and publication information. [1]

Research Profile

The supplied profile places Rhea Coler within biomedical sciences and identifies Seattle Children’s Research Institute in the United States as the institutional affiliation. Biomedical sciences encompass a broad range of research areas concerned with biological systems, human health, disease mechanisms, and the development of scientific approaches to health-related questions. A detailed description of a researcher’s particular specialization requires verification through publications, institutional information, and relevant scholarly records. [1]

Research Contributions

Evaluating research contributions in biomedical sciences requires consideration of the questions investigated, the reliability of the methods used, the originality of the findings, and the extent to which results advance knowledge. Research contributions may include original investigations, collaborative studies, methodological developments, evidence synthesis, and the development of resources that support subsequent scientific work. [2]

Publications

The supplied bibliometric information reports 165 documents associated with the Scopus author identifier 7004227435. This figure is presented as provided and has not been independently checked against a live database snapshot. A publication-level assessment should confirm the author’s identity across records and distinguish research articles from reviews, conference papers, and other document types where relevant. Citation patterns can provide additional context, but citation counts alone do not establish the validity or importance of an individual paper. [1] [2]

Research Impact

The reported total of 12,421 citations and h-index of 54 provides a quantitative description of the scholarly attention associated with the supplied author profile. Citation indicators can help identify patterns of scholarly engagement, locate influential publications, and compare research activity when appropriate disciplinary and career-stage context is available. However, citation databases vary in their coverage, and citation totals may include different document types and reflect multiple reasons for referencing a publication. [1]

Award Suitability

The Best Researcher Award recognizes scholarly achievement and provides a framework for reviewing research productivity, scientific contribution, and professional impact. The information supplied for Rhea Coler includes a stated institutional affiliation, a biomedical sciences subject classification, and three bibliometric indicators. These details may serve as inputs to an award assessment, subject to verification and the eligibility and evaluation criteria established by the organizing body. [3]

Conclusion

This academic recognition profile summarizes the supplied information for Rhea Coler, identified with Seattle Children’s Research Institute in the United States and the subject area of biomedical sciences. The reported record includes 165 documents, 12,421 citations, and an h-index of 54. These indicators offer a useful starting point for understanding publication activity and scholarly engagement, but they require appropriate context and verification. [1]

References

  1. Elsevier. (2026). Scopus author details: Rhea Coler, Author ID 7004227435. Scopus.
    https://www.scopus.com/authid/detail.uri?authorId=7004227435
  2. Schistosomiasis vaccine SchistoShield® induces functional immune memory responses in US and African populations.
    https://doi.org/10.1038/s41541-026-01501-0
  3. The Scientist Global Awards. (2026). Official award website.
    https://thescientists.net/

Zhang Guowei | Pharmaceutical Sciences | Excellence in Research

Posted on by The Scientist

Mr. Zhang Guowei | Pharmaceutical Sciences | Excellence in Research

Associate Professor |  Hebei University | China

Dr. Zhang Guowei is an active researcher whose work advances the understanding of psychological health, behavioral patterns, and population-level mental well-being, particularly among young adults in contemporary social environments. His academic influence is demonstrated through 347 citations, 20 publications, and an h-index of 10, reflecting a growing global presence and measurable scholarly impact. His research portfolio integrates empirical analysis, psychometric assessment, and digital-behavior analytics to examine how social, environmental, and technological factors shape mental health outcomes. Dr. Zhang’s contributions include impactful studies on anxiety, depression, insomnia, and PTSD among university students, offering timely insights into evolving psychosocial challenges in the post-pandemic era. His work on time-based online survey patterns and their relationship with offline psychological symptoms provides a novel methodological approach, highlighting his ability to connect digital behavioral traces with real-world psychological states. Through these interdisciplinary inquiries, he addresses urgent public-health concerns and informs evidence-based interventions. With a collaborative network spanning over 70 co-authors, Dr. Zhang actively participates in multi-institutional and cross-regional research efforts. This broad collaborative engagement enhances the robustness of his findings and contributes to the global dialogue on mental health resilience, student well-being, and psychosocial risk assessment. His publications in reputable international journals underscore his commitment to research transparency, open access, and data-driven decision-making. Dr. Zhang’s ongoing work strengthens the academic and societal understanding of mental-health dynamics in rapidly changing environments, emphasizing early detection, preventive strategies, and policy relevance. His scholarly trajectory continues to advance applied psychological research, contributing meaningful evidence to public health systems, educational institutions, and community well-being initiatives worldwide.

Profiles: Scopus | ORCID | ResearchGate

Featured Publications

  1. Xiong, J.-M., Wang, J.-Y., Liu, Y., … Zhang, G.-W. (2023). Study on prescription medication mode and mechanism of traditional Chinese medicine in the treatment of noncritical COVID-19 based on data mining.

  2. Fu, Z.-T., Wang, J.-Y., Liu, Y., … Zhang, G.-W. (2023). The mechanism of TCM prevention and treatment of heavy COVID-19 based on data mining and network pharmacology.

  3. Zhang, L.-H., Zhang, W.-Y., Xiong, J.-M., … Zhang, G.-W. (2022). Mechanisms of Compound Kushen Injection for the treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation.

  4. Cui, Q., Ma, Y., Yu, H., … Zhang, G.-W. (2021). Systematic analysis of the mechanism of hydroxysafflor yellow A for treating ischemic stroke based on network pharmacology technology.

  5. Zhang, L., Zhang, W., Xiong, J., … Zhang, G.-W. (2020). Mechanisms of Compound Kushen Injection for treatment of bladder cancer based on bioinformatics and network pharmacology with experimental validation.

Jan Radford | Pharmaceutical Sciences | Best Researcher Award

Posted on by The Scientist

Prof. Jan Radford | Pharmaceutical Sciences | Best Researcher Award

Prof in General Practice | University of Tasmania | Australia

Professor Jan Radford is a distinguished academic in general practice and medical education, currently based at the Tasmanian School of Medicine, University of Tasmania. With over three decades of professional and academic experience, she has contributed extensively to curriculum design, health professional education, and research capacity building within primary care. She has authored 59 peer-reviewed publications, which have collectively received over 535 citations, reflecting her sustained influence in the field. Professor Radford’s scholarly and leadership contributions span undergraduate, postgraduate, and vocational levels of medical education. As a long-serving faculty member, she has played a pivotal role in shaping the University of Tasmania’s medical curriculum, particularly through initiatives such as the development of innovative rural and aged care placements. Her leadership as Director of the Launceston Clinical School (2022–2024) further strengthened community-based clinical education and interprofessional collaboration across Tasmania. Nationally, she has held major roles in the Royal Australian College of General Practitioners (RACGP), notably serving as Censor-in-Chief, where she oversaw educational quality assurance, specialty recognition, and the advancement of Indigenous health education. Her work in developing the GP MAGIC framework and establishing Tasmania’s practice-based research network has fostered practitioner-led inquiry and evidence-informed primary care. A 2017 Churchill Fellow, Professor Radford investigated the use of routinely collected general practice electronic health data to enhance patient outcomes. This aligns with her ongoing research focus on integrating e-health data, clinical audit, and educational innovation to improve general practice systems and learning environments. Through her extensive collaborations and commitment to translating research into practice, Professor Radford continues to influence healthcare education and delivery in Australia and beyond, contributing meaningfully to the advancement of community-oriented, data-informed primary care.

Profiles: Google Scholar | Scopus | ORCID | ResearchGate

Featured Publications

  1. Watts, G. F., Sullivan, D. R., Hare, D. L., Kostner, K. M., Horton, A. E., Bell, D. A., Brett, T., Radford, J., et al. (2021). Integrated guidance for enhancing the care of familial hypercholesterolaemia in Australia. Heart, Lung and Circulation, 30(3), 324–349. https://doi.org/10.1016/j.hlc.2020.10.013 — 108 citations

  2. Fan, S., Radford, J., & Fabian, D. (2016). A mixed-method research to investigate the adoption of mobile devices and Web 2.0 technologies among medical students and educators. BMC Medical Informatics and Decision Making, 16(1), 43. https://doi.org/10.1186/s12911-016-0282-4 — 52 citations

  3. Bezabhe, W. M., Bereznicki, L. R., Radford, J., Wimmer, B. C., Salahudeen, M. S., et al. (2022). Oral anticoagulant treatment and the risk of dementia in patients with atrial fibrillation: A population-based cohort study. Journal of the American Heart Association, 11(7), e023098. https://doi.org/10.1161/JAHA.121.023098 — 46 citations

  4. Castelino, R. L., Saunder, T., Kitsos, A., Peterson, G. M., Jose, M., Wimmer, B., Radford, J., et al. (2020). Quality use of medicines in patients with chronic kidney disease. BMC Nephrology, 21(1), 216. https://doi.org/10.1186/s12882-020-01849-7 — 37 citations

  5. Bezabhe, W. M., Bereznicki, L. R., Radford, J., Wimmer, B. C., & Curtain, C. (2021). Ten-year trends in the use of oral anticoagulants in Australian general practice patients with atrial fibrillation. Frontiers in Pharmacology, 12, 586370. https://doi.org/10.3389/fphar.2021.586370 — 36 citations